About Organ Transplantation
Organ transplantation refers to the replacement of the diseased or damaged organ with a healthy organ. The organs may be donated by live donors or harvested from a brain dead organ donors. Organ dysfunction caused due to severe injuries cancer, organ failure and/or genetic disorders necessitates the requirement for organ transplant procedures.
|High Growth Market||Asia-Pacific|
|Unit||Value (USD Billion)|
Ongoing awareness of developments in medical technologies is integral to understanding and utilizing the best options available. Development in the field of organ transplantation such as machine reperfusion of organs have the potential to transform and increase the opportunities for patients needing a transplant. Repair and regeneration of organs will have a substantial impact on the number of suitable organ donors. Both mechanical and biological (stem cell) organ replacement therapies may change the profile of people needing an organ transplant. Work with the eye and tissue banking sector will continue to foster a strong national network, and consistency and sustainability of the sector. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Organ Transplantation market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Bio Med Pvt. Ltd. (United States), Terumo Medical Corporation (United States), Preservation Solutions, Inc. (United States), Transonic (United States), Pfizer, Inc. (United States), TransMedic, Inc. (United States), GlaxoSmithKline Plc. (United Kingdom), OrganOX Limited (United Kingdom), Transplant Biomedical (United Kingdom), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland) and Accord Healthcare GmbH (Spain) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Astellas Pharma, Inc (Japan) and Veloxis Pharmaceuticals A/S (Denmark).
AMA Research has segmented the market of Global Organ Transplantation market by Type (Preservation Solutions, Transplant Diagnostics, Tissue Products and Others (Immunosuppressive drugs)), Application (Children, Adults and Senior Citizens) and Region. On the basis of Type, Tissue Product are dominating the market in the year 2022
On the basis of geography, the market of Organ Transplantation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Organ Type, the sub-segment i.e. Heart will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End user, the sub-segment i.e. Hospitals will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Type of Transplant , the sub-segment i.e. Autograft will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Technology Advancement and Innovation In Medical Sector and Organ and Tissue Procurement And Its preservation
Market Growth Drivers:
Increasing Number of Chronic Diseases and Organ Failure, Growing Consumption of Alcohol and Unhealthy Diet and Increasing Relevance of Renal Diseases
Huge Gap Between Demand and Supply For Organ Transplantation
High Cost of Transplantation, Limited Number of Donors and Increasing Incidences And Organ Failure
Rising Aging Population and Changing Lifestyle
Organs that have been successfully transplanted include the heart, kidneys, brain, liver, lungs, pancreas, intestine, and thymus. From the year 2000 and forward, there have been approximately 2,200 lung transplants performed each year worldwide. From between 2000 and 2006, the median survival period for lung transplant patients has been 5-and-a-half years, meaning half the patients survived for a shorter time period and a half survived for a longer period. In China, a kidney transplant operation runs for around USD 70,000, liver for USD 160,000, and heart for USD 120,000. Although these prices are still unattainable to the poor, compared to the fees of the United States, where a kidney transplant may demand USD 100,000, a liver USD 250,000, and a heart USD 860,000, Chinese prices have made China a major provider of organs and transplantation surgeries to other countries.
According to National Kidney Foundation “Around 3,000 new patients are added to the kidney waiting list each month worldwide.” According to the United Network for organ sharing, in the United States every day 21 people die to wait for an organ, and more than 120,000 men, women, and children await lifesaving organ transplants. and According to the Health Resources and Services Administration, till May 2017, there were around 117,829 patients waiting for organ transplants in the U.S., among them about 97,610 were waiting for kidney transplants. However, only 11,061 transplant procedures were performed from January to April 2017.
Key Target Audience
Pharmaceutical Companies, Research and Development (R&D) Companies, Independent Research Laboratories, Market Research and Consulting Service Providers, Medical Research Laboratories, Academic Medical Institutes and Universities and Others
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.